IMUX Trial readout: Saturday, November 28, 2026
CompanyImmunic, Inc. (IMUX)
EventTrial readout
DateSaturday, November 28, 2026
MarketUS listing
SourceCT.gov registry · confidence 50% · primary source ↗
Est. Completion: 2026-11. Status: ACTIVE_NOT_RECRUITING. Title: Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.